tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vor Bio price target lowered to $40 from $43 at JPMorgan
PremiumThe FlyVor Bio price target lowered to $40 from $43 at JPMorgan
1M ago
Vor Biopharma strengthens board following $150M private placement
Premium
Company Announcements
Vor Biopharma strengthens board following $150M private placement
1M ago
Vor Bio initiated with a Buy at TD Cowen
Premium
The Fly
Vor Bio initiated with a Buy at TD Cowen
1M ago
Vor Bio assumed with a Neutral at Wedbush
PremiumThe FlyVor Bio assumed with a Neutral at Wedbush
2M ago
Vor Biopharma Reports Q3 2025 Financial Results and Strategic Updates
Premium
Company Announcements
Vor Biopharma Reports Q3 2025 Financial Results and Strategic Updates
2M ago
Vor Bio price target lowered to $32 from $55 at H.C. Wainwright
Premium
The Fly
Vor Bio price target lowered to $32 from $55 at H.C. Wainwright
3M ago
Vor Bio achieves primary endpoint in Stage A of Phase 3 study of telitacicept
PremiumThe FlyVor Bio achieves primary endpoint in Stage A of Phase 3 study of telitacicept
3M ago
Vor Biopharma Appoints New Chief Medical Officer
Premium
Company Announcements
Vor Biopharma Appoints New Chief Medical Officer
3M ago
Vor Bio appoints Sokolove as Chief Medical Officer
Premium
The Fly
Vor Bio appoints Sokolove as Chief Medical Officer
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100